Atlas Trials

IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients

Clinical trial NCT02854059 · TERMINATED

Trial details

NCT number
NCT02854059
Sponsor
Hansa Biopharma AB
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Purpura, Thrombotic Thrombocytopenic
Start date
2016-09-01
Primary completion
2017-01-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.